II. Epidemiology
- Incidence: 1 to 1.5 per 100,000
- Cerebroarterial Dissections (Carotid Artery and Vertebral Artery) are uncommon (<2%) causes of Ischemic CVA
- Age
- Younger patients account for up to 25% of Vertebral Dissection related Ischemic CVA
- Peak Incidence age 50-60 years
- Gender
- Women are affected at a younger age than men
III. Pathophysiology
- Vertebral Artery Dissection most commonly occurs with compression at one of two foramina
- Cervical foramen at C1-2
- Transverse foramen at C5-6
-
Vertebral Artery media tear (middle muscular, arterial layer) allowing blood intrusion into arterial wall
- Resulting intramural thrombus occludes vessel with risk of CVA
IV. Causes
V. Types
- Ischemic Vertebral Artery Dissection
- Resulting cerebral ischemia or infarction
- Many dissections heal spontaneously and occluded vessels may be compensated by opposite Vertebral Artery
- Rupture of Intradural Vertebral Artery dissecting aneurysm (hemorrhagic)
- Subarachnoid Hemorrhage
- Unstable with high risk of recurrent bleeding (70% of cases, most within first week, and mortality 47%)
VI. Findings
- Extracranial Vertebral Artery Dissection (primarily at C1-2)
- Occipitocervical region severe pain
- Vertebrobasilar Ischemia or Infarction Symptom
- Vertebrobasilar Infarction
- Cerebellar infarction
- Spinal Cord Infarction
- Wallenberg Syndrome (lateral Medullary ischemia)
- Dysmetria, Ataxia and ipsilateral Hemiplegia
- Intracranial Vertebral Artery Dissection
- Subarachnoid Hemorrhage in 50% of cases
- High rebleeding rate, poor prognosis, high mortality
- Responsible for up to 10% of non-Traumatic Subarachnoid Hemorrhage
- May be minor in some cases
VII. Imaging
- MR Angiogram
- Has largely replaced CT Angiogram as gold standard, with similar efficacy
- CT Angiogram
- As with MRA, CT angiogram has high Test Sensitivity
VIII. Prognosis
- Extracranial Vertebral Artery Dissection
- No deficit 50%
- Mild deficit 21%
- Moderate to severe deficit 25%
- Mortality 4%
- Intracranial Vertebral Artery Dissection
- Associated with severe neurologic deficits
IX. Management
-
Anticoagulation (unless contraindicated, e.g. Hemorrhage)
- Intravenous Heparin, then
- Oral Anticoagulant
- Surgical interventions
- Endovascular procedures
- Vascular or Neurosurgery
X. References
- Hussein and Leiman (2022) Crit Dec Emerg Med 36(8): 4-8
- Park (2008) J Korean Neurosurg Soc 44:109-15 [PubMed]